Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure.

Cochino, Alexis Virgil; Farkas, Oana Maria; Ioan, Andreea

Cochino, Alexis Virgil; Farkas, Oana Maria; Ioan, Andreea.

Cochino AV; Department of Pediatrics, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania; Department of Clinical Immunology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Lacul Tei Boulevard, 120, Bucharest, Romania.
Farkas OM; Department of Clinical Immunology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Lacul Tei Boulevard, 120, Bucharest, Romania.
Ioan A; Department of Clinical Immunology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Lacul Tei Boulevard, 120, Bucharest, Romania. Electronic address: andreea.ioan@rez.umfcd.ro.

J Infect ; 85(3): e62-e65, 2022 09.

Article en En | MEDLINE | ID: mdl-35724754

Asunto(s)

COVID-19; SARS-CoV-2; Niño; Humanos; Inmunosupresores/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google